Persistency patterns of treatment with rivastigmine versus donepezil in a medicaid population

被引：0
|
作者：
Singh, G
Thomas, S
Bharathi, V
Wong, K
Mithal, A
机构：
来源：
ANNALS OF NEUROLOGY | 2004年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [41] Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period
    Bullock, R
    Touchon, J
    Bergman, H
    Gambina, G
    He, YS
    Rapatz, G
    Nagel, J
    Lane, R
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) : 1317 - 1327
  • [42] The Impact of a Long-Term Rivastigmine and Donepezil Treatment on All-Cause Mortality in Patients With Alzheimer's Disease
    Kazmierski, Jakub
    Messini-Zachou, Chaido
    Gkioka, Mara
    Tsolaki, Magda
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2018, 33 (06): : 385 - 393
  • [43] Rivastigmine can stabilize cognitive and behavioral decline in patients with probable Alzheimer's disease who worsen on donepezil treatment
    Edwards, K
    O'Connor, J
    Button, J
    Goodman, W
    Norton, J
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S79 - S79
  • [44] Rivastigmine can stabilize cognitive and behavioral decline in patients with probable Alzheimer's disease who worsen on donepezil treatment
    Edwards, KR
    O'Connor, J
    Button, J
    Goodman, WA
    Norton, J
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 254 - 255
  • [45] Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer's disease
    Scacchi, Renato
    Gambina, Giuseppe
    Broggio, Elisabetta
    Corbo, Rosa Maria
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2014, 29 (06) : 610 - 615
  • [46] Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Tan, Chen-Chen
    Yu, Jin-Tai
    Wang, Hui-Fu
    Tan, Meng-Shan
    Meng, Xiang-Fei
    Wang, Chong
    Jiang, Teng
    Zhu, Xi-Chen
    Tan, Lan
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 (02) : 615 - 631
  • [47] Response to comments on Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil
    Auriacombe, S
    Pere, JJ
    CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (06) : IV - VI
  • [48] Utilization Patterns of Stimulants in ADHD in the Medicaid Population: A Retrospective Analysis of Data from the Texas Medicaid Program
    Lawson, Kenneth A.
    Johnsrud, Michael
    Hodgkins, Paul
    Sasane, Rahul
    Crismon, M. Lynn
    CLINICAL THERAPEUTICS, 2012, 34 (04) : 944 - 956
  • [49] Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine
    Sicras-Mainar, A.
    Vergara, J.
    Leon-Colombo, T.
    Febrer, L.
    Rejas-Gutierrez, J.
    REVISTA DE NEUROLOGIA, 2006, 43 (08) : 449 - 453
  • [50] Racial and Ethnic Disparities in the Treatment of a Medicaid Population with Schizophrenia
    Horvitz-Lennon, Marcela
    McGuire, Thomas G.
    Alegria, Margarita
    Frank, Richard G.
    HEALTH SERVICES RESEARCH, 2009, 44 (06) : 2106 - 2122
12345